JP2024523884A5 - - Google Patents
Info
- Publication number
- JP2024523884A5 JP2024523884A5 JP2023577510A JP2023577510A JP2024523884A5 JP 2024523884 A5 JP2024523884 A5 JP 2024523884A5 JP 2023577510 A JP2023577510 A JP 2023577510A JP 2023577510 A JP2023577510 A JP 2023577510A JP 2024523884 A5 JP2024523884 A5 JP 2024523884A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- labeled
- radiolabeled compound
- ascorbic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108608.7A GB202108608D0 (en) | 2021-06-16 | 2021-06-16 | Preparation of a ph-adjusted ascorbic acid solution |
| GB2108608.7 | 2021-06-16 | ||
| PCT/EP2022/066481 WO2022263592A1 (en) | 2021-06-16 | 2022-06-16 | Preparation of a ph-adjusted ascorbic acid solution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523884A JP2024523884A (ja) | 2024-07-02 |
| JP2024523884A5 true JP2024523884A5 (cg-RX-API-DMAC7.html) | 2025-06-11 |
Family
ID=76954449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577510A Pending JP2024523884A (ja) | 2021-06-16 | 2022-06-16 | pH調整されたアスコルビン酸溶液の調製 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240350683A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355368A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024523884A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117500525A (cg-RX-API-DMAC7.html) |
| GB (1) | GB202108608D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022263592A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201915206D0 (en) | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0520527D0 (en) | 2005-10-10 | 2005-11-16 | Ge Healthcare Ltd | Automated method |
| CN102458396B (zh) * | 2009-04-15 | 2017-05-10 | 兰休斯医疗成像公司 | 使用抗坏血酸稳定化放射性药物组合物 |
| AU2011213568B2 (en) | 2010-02-08 | 2016-05-12 | Lantheus Medical Imaging, Inc. | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
| GB201915206D0 (en) * | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
-
2021
- 2021-06-16 GB GBGB2108608.7A patent/GB202108608D0/en not_active Ceased
-
2022
- 2022-06-16 EP EP22734289.6A patent/EP4355368A1/en active Pending
- 2022-06-16 US US18/569,177 patent/US20240350683A1/en active Pending
- 2022-06-16 CN CN202280043073.1A patent/CN117500525A/zh active Pending
- 2022-06-16 WO PCT/EP2022/066481 patent/WO2022263592A1/en not_active Ceased
- 2022-06-16 JP JP2023577510A patent/JP2024523884A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016201367B2 (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid | |
| CA1177091A (en) | Cationic lipophilic complexes of 99m tc and their use for myocardial and hepatobiliary imaging | |
| EP0031121B1 (en) | Method, composition and kit for stabilizing radiolabeled compounds | |
| Haveman et al. | State of the art procedures towards reactive [18F] fluoride in PET tracer synthesis | |
| CN104470547B (zh) | 利用筒状物合成放射性药物的方法 | |
| Molavipordanjani et al. | Basic and practical concepts of radiopharmaceutical purification methods | |
| Iwata et al. | A new, convenient method for the preparation of 4-[18F] fluorobenzyl halides | |
| KR20120034724A (ko) | 저압 내지 중간압 액체 크로마토그래피의 사용에 의한 방사성추적자의 정제 | |
| JPS645256B2 (cg-RX-API-DMAC7.html) | ||
| JP2024518319A5 (cg-RX-API-DMAC7.html) | ||
| Loc'h et al. | Preparation of [76Br] FLB 457 and [76Br] FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET | |
| Käkelä et al. | Adventures in radiosynthesis of clinical grade [68Ga] Ga-DOTA-Siglec-9 | |
| US20200047158A1 (en) | Solid phase conditioning | |
| CN117500525A (zh) | pH调节的抗坏血酸溶液的制备 | |
| Teodoro et al. | A high-yield automated radiosynthesis of the alpha-7 nicotinic receptor radioligand [18F] NS10743 | |
| US5738836A (en) | Composition for stabilizing radiolabeled organic compounds | |
| Ryzhikov et al. | Preparation of [18F] flumazenil, a potential radioligand for PET imaging of central benzodiazepine receptors, by isotope exchange | |
| CN101133005B (zh) | 使用固体载体清除剂纯化放射性标记产物的方法 | |
| WO2009029633A1 (en) | Synthesis of [18f]-labelled alkyl mesylates using fluorous spe separation | |
| US12312653B2 (en) | Systems and methods for generating lead | |
| KR20240021888A (ko) | 표지 단계 동안 낮은 물 함량을 갖는 [18f] 방사성표지된 화합물을 제조하는 방법 | |
| Welch et al. | Potential labeling of monoclonal antibodies with positron emitters | |
| Gu et al. | Labeling strategies with F-18 for positron emission tomography imaging | |
| Pfeiffer | Quality Control of Radiopharmaceuticals: Recent Developments in Analytical Techniques | |
| RU2760273C1 (ru) | Способ получения комплексов на основе изотопа галлий-68 |